Marimedis - Company finances
|
EUR
|
2023
From: 2023-05-16
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|
|
Financial data
|
|||
| Sales revenue | 12,460 | 75,851 | 12,489 |
| Profit before tax | - | - | - |
| Net profit | -8,120 | -10,714 | 365 |
| Equity | -5,620 | -16,333 | -15,969 |
| Liabilities | 22,155 | 27,218 | 21,708 |
| Non-current assets | 1,411 | 3,901 | 3,421 |
| Current assets | 15,124 | 6,984 | 2,318 |
| Total assets | 16,535 | 10,885 | 5,739 |
|
Taxes paid
|
|||
| STI taxes | - | - | 1,184 |
|
Financial indicators
|
|||
| Revenue change y/y | - | +508.8% | -83.5% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -49.1% | -98.4% | 6.4% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | - | - | - |
| Profit margin Net profit margin. Shows the overall profitability of the company. | -65.2% | -14.1% | 2.9% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | - |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - | - |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 9,968 | 37,926 | 5,551 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Marimedis - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2025-09-16 | 2025-09-18 | 17.74 |
| 2025-09-07 | 2025-09-14 | 5.44 |
| 2025-08-31 | 2025-09-03 | 5.44 |
| 2025-08-19 | 2025-08-29 | 5.44 |
| 2025-07-28 | 2025-08-12 | 22.18 |
| 2025-07-26 | 2025-07-27 | 21.92 |
| 2025-07-24 | 2025-07-25 | 22.18 |
| 2025-07-16 | 2025-07-23 | 21.92 |
| 2025-06-17 | 2025-07-15 | 16.48 |
| 2025-06-11 | 2025-06-16 | 11.04 |
| 2025-06-08 | 2025-06-09 | 11.04 |
| 2025-05-16 | 2025-06-04 | 11.04 |
| 2025-05-04 | 2025-05-15 | 5.60 |
| 2025-04-30 | 2025-04-30 | 5.44 |
| 2025-04-24 | 2025-04-29 | 5.60 |
| 2025-04-16 | 2025-04-23 | 5.44 |
| 2025-03-18 | 2025-03-26 | 11.15 |
| 2025-02-18 | 2025-03-17 | 5.71 |
| 2025-01-24 | 2025-02-17 | 0.27 |
| 2025-01-22 | 2025-01-23 | 38.18 |
| 2025-01-16 | 2025-01-21 | 37.91 |
| 2025-01-02 | 2025-01-15 | 33.06 |
| 2024-12-22 | 2024-12-31 | 33.06 |
| 2024-12-17 | 2024-12-20 | 33.06 |
| 2024-10-24 | 2024-11-03 | 0.58 |
| 2024-07-26 | 2024-08-15 | 0.16 |
| 2024-07-24 | 2024-07-25 | 182.44 |
| 2024-07-16 | 2024-07-23 | 182.28 |
| 2024-06-18 | 2024-06-19 | 182.28 |
| 2024-03-18 | 2024-03-19 | 175.62 |
| 2024-02-27 | 2024-03-17 | 0.10 |
| 2024-02-19 | 2024-02-26 | 205.64 |
| 2024-01-16 | 2024-02-01 | 0.01 |
| 2023-07-25 | 2023-07-31 | 0.01 |
| 2023-07-24 | 2023-07-24 | 4.44 |
| 2023-07-18 | 2023-07-23 | 4.43 |
| 2023-06-16 | 2023-06-22 | 3.32 |
Marimedis - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-07-06 | 2026-07-07 | 42.09 |
| 2026-06-28 | 2026-07-05 | 42.0 |
| 2026-06-04 | 2026-06-05 | 0.01 |
| 2026-05-13 | 2026-05-13 | 0.01 |
| 2026-04-11 | 2026-04-11 | 0.01 |
| 2025-07-13 | 2025-07-25 | 6.0 |
| 2025-07-10 | 2025-07-12 | 5.9 |
| 2025-07-09 | 2025-07-09 | 181.55 |
| 2025-07-08 | 2025-07-08 | 176.43 |
| 2025-07-04 | 2025-07-07 | 176.23 |
| 2025-07-02 | 2025-07-03 | 176.05 |
| 2025-07-01 | 2025-07-01 | 301.0 |
| 2025-06-30 | 2025-06-30 | 300.68 |
| 2025-06-28 | 2025-06-29 | 300.82 |
| 2025-06-12 | 2025-06-27 | 5.6 |
| 2025-06-02 | 2025-06-11 | 0.48 |
| 2025-05-29 | 2025-05-30 | 426.36 |
| 2025-01-24 | 2025-01-24 | 2.63 |
| 2025-01-22 | 2025-01-23 | 4.63 |
| 2025-01-08 | 2025-01-21 | 4.56 |
| 2025-01-01 | 2025-01-07 | 57.48 |
| 2024-12-30 | 2024-12-31 | 57.44 |
| 2024-12-29 | 2024-12-29 | 46.44 |
| 2024-12-08 | 2024-12-28 | 46.11 |
| 2024-12-04 | 2024-12-07 | 46.05 |
| 2024-12-03 | 2024-12-03 | 133.17 |
| 2024-11-28 | 2024-12-02 | 87.12 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Marimedis, UAB (code 306319680) is a Private Limited Liability Company operating in retail sale of hardware, building materials, paints and glass. In the latest financial year 2025, the company generated revenue of €12.5K and reported a net profit of €365, moving back into profit after losses of €8.1K in 2023 and €10.7K in 2024. Revenue was sharply lower than in 2024, reflecting an 83.5% year-on-year decline, but it was broadly in line with 2023 on a two-year basis. The profit margin improved to 2.9% in 2025. The balance sheet remained small, with total assets of €5.7K, equity of -€16.0K and liabilities of €21.7K. Assets decreased from €10.9K in 2024, while liabilities also eased. The asset turnover ratio was 2.18x, and revenue per employee stood at €6.2K, indicating a limited operating scale. Profit per employee was €182. The negative equity position means leverage and return ratios should be interpreted with caution.